To explore the role of CCL28-induced immunosuppression in BF BSH-accelerated CRC, anti-CCL28 or anti-CD25 neutralizing antibody were applied to block CCL28 or CD25+FOXP3+ Treg cells27,28. The gene discussed is FOXP3; the disease is colorectal carcinoma.